chronic kidney disease
Conditions
Interventions
Traetment group:Fresubin-Oral Nutritional Supplement
Controled group:General medical treatment
Sponsors
Department of nephrology in Nanfang Hospital, Southern Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 79 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18-80 years old maintenance dialysis (MHD) patients; 2. Dialysis age = 3 months; 3. Dietary energy intake <30 kcal/kg IBW/day; 4. Signed the written informed consent.
Exclusion criteria
Exclusion criteria: 1. Inability to eat properly; 2. Concomitant diseaseshyperthyroidism, acute infectious diseases, diabetes, cirrhosis, active autoimmune disease, cancer; 3. Multiple organ failure; 4. Received intravenous albumin treatment within the last 6 months; 5. Cognitive, communication disorder, mental instability; 6. Be allergic or intolerant to any ingredient found in the study product; 7. Subject is considered unsuitable for the study based on the study physician's assessment.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| KDQOL-SF questionnaire; | — |
Primary
| Measure | Time frame |
|---|---|
| Phase Angle; | — |
Countries
China
Contacts
Public ContactMin Liang
Department of nephrology in Nanfang Hospital, Southern Medical University, Guangzhou, China
Outcome results
None listed